There is a condition, documented by the CDC, the Cleveland Clinic, and the Merck Manual, where tapeworm larvae travel through the bloodstream, cross into the brain, and form cysts in the central nervous system.

Those cysts cause inflammation, lesions, and a waxing and waning pattern of neurological symptoms.

The condition is called neurocysticercosis. And the list of symptoms it causes is virtually the same as the MS symptom list.

This is well understood in medical science. It is in every major medical reference on the planet.

And yet virtually no MS patient has ever been tested for it.

This post explains why that matters and what the research actually shows.

Part 6 of the True Cause of MS Series

This post is part of an ongoing series examining the infectious causes of MS and other chronic neurological diseases. Previous topics in this series have covered MS and fungus, MS and Lyme disease, MS and malaria-like protozoa, and MS and large roundworms.

The core principle underlying all of it: MS is not one disease caused by one pathogen.

What research increasingly shows is that MS patients are in a state of dysbiosis, meaning a disrupted microbial ecosystem where multiple infections are present simultaneously. Fungus, Borrelia (Lyme disease), malaria-like protozoa, filarial roundworms and other parasites have all been linked to MS in peer-reviewed scientific literature.

Tapeworm larvae are not replacing those findings. They are adding to the picture.

And based on the available evidence, tapeworm larval cysts may be among the most destructive of these infections because of their size and what they do when they form cysts inside the brain and spinal cord.

Until these infections are identified and treated, full recovery is not possible.

 

What Is Neurocysticercosis?

Neurocysticercosis (NCC) is an infection of the central nervous system caused by tapeworm larval cysts.

This is not a fringe or alternative medicine concept. It is recognized and documented by:

• The Centers for Disease Control and Prevention (CDC)
• The Cleveland Clinic
• The Merck Manual
• Peer-reviewed neurology journals worldwide

According to major medical reviews, NCC is considered the most common parasitic infection of the human central nervous system in the world. It is responsible for up to 30% of adult-onset epilepsy cases globally.

It is widely referred to in the medical literature as “the great imitator.” It mimics almost every neurological disease known to medicine.

In practice, neurocysticercosis can look indistinguishable from MS on MRI and by symptoms, to the point that neurologists sometimes cannot tell them apart without very careful follow-up and additional testing.

 

How People Become Infected

Most people assume tapeworm infection requires eating undercooked pork. That assumption is incorrect, and it is one reason so many cases go undetected.

Tapeworm eggs can be ingested from:

• Raw fruits and vegetables, especially produce imported from endemic regions including Mexico, Central America, South America, Asia, and Africa, all of which are major sources for North American grocery stores
• Contaminated water or soil
• Food handlers who carry tapeworms and do not practice proper hand hygiene
• Pets including dogs, cats, and farm animals
• Self-infection, if a person carries an adult tapeworm and hygiene is not adequate

 After eggs are swallowed, they hatch in the small intestine and become what are called oncospheres, which are immature larvae. Instead of developing into adult tapeworms in the gut, these larvae enter the bloodstream and migrate to:

• The liver
• The heart
• The lungs
• The eyes
• The muscles
• The central nervous system, meaning the brain and spinal cord

Once inside the central nervous system, the larvae form fluid-filled cysts called cysticerci. Each cyst is a protective sac that can contain multiple developing larvae inside it.

Dr. Alan MacDonald, whose research is discussed in detail below, found cysts in the spinal fluid of every MS subject tested.

The cyst wall acts as a shield, protecting the larvae from the immune system. As a result, these cysts can sit inside the central nervous system undetected for years, or even decades, with few or no symptoms.

When a cyst begins to degenerate or rupture, the immune system detects it and responds with full force. The result: inflammation, edema, and a cascade of neurological symptoms.

In patients diagnosed with MS, this process may look exactly like an MS flare.

 

The Four Stages of Tapeworm Cysts and the MS Parallel

Understanding how tapeworm cysts progress through their life cycle helps explain something that has puzzled neurologists for decades: why MS lesions appear to come and go.

Stage 1: Alive and Intact

The cyst is alive. The wall is intact. The immune system largely does not detect it. Symptoms are few or absent.

Stage 2: Degenerating

The cyst begins to break down. The wall becomes leaky. The immune system activates a full inflammatory response. This is when symptoms appear or worsen sharply: inflammation, swelling, and neurological deterioration.

Stage 3: Granular

The immune system works to wall off the dying parasite. A granuloma forms around it.

Stage 4: Calcified

The cyst is dead. A calcium deposit remains in its place.

 

The Direct MS Parallel

Here is what is striking about this four-stage progression when placed next to standard MS imaging language:

• MS neurologists describe: “enhancing lesions” (active inflammation) vs. “non-enhancing lesions” (inactive)
• NCC radiologists describe: “active viable cysts” (inflammatory) vs. “inactive calcified lesions” (dead)

 These are describing the same biological process in completely different language. The same waxing and waning pattern on MRI. What MS medicine calls a “mysterious immune flare with unknown trigger” may be a parasitic cyst going through its natural life cycle.

 

Animal Evidence

In animal studies involving sheep, goats, and primates, tapeworm cysts in the central nervous system have been shown to produce demyelination (myelin destruction) in the white matter beside the cysts.

This is documented in both veterinary literature and experimental research. It is exactly the same process that occurs in multiple sclerosis.

 

The Symptom Overlap: NCC vs. MS

The following symptom data comes from major peer-reviewed clinical reviews, the NIH, the CDC, and the Cleveland Clinic.

Neurological Symptoms Documented in NCC

• Seizures and epilepsy, present in 70 to 90% of symptomatic NCC patients in some large clinical series
• Severe chronic headaches, documented in 30 to 50% of NCC cases across studies
• Focal neurological deficits including weakness, sensory loss, and visual changes, in approximately 8 to 16% of patients
• Raised intracranial pressure, hydrocephalus, and chronic meningitis, in 12 to 30% of cases
• Gait abnormalities, ataxia (impaired walking, speaking, swallowing, and eye movement), poor coordination, and involuntary movements
• Brainstem dysfunction and spasticity

 That is virtually identical to the MS symptom list.

 

Neuropsychiatric Symptoms Documented in NCC

This aspect of NCC is frequently overlooked, and it has significant implications for people being diagnosed with conditions beyond MS.

• Depression is the most frequent psychiatric diagnosis in NCC patients. Present in over 50% of outpatients in a published Brazilian clinical series
• Cognitive dysfunction and dementia, documented in up to 20% of NCC patients in some cohorts. In some cases, dementia is the only symptom. No seizures. No obvious neurological signs. Just a gradual loss of mental function caused by tapeworm cysts in the brain
• Psychosis including paranoia, hallucinations, and behavioral changes, documented in up to approximately 5% of NCC patients
• Personality changes, anxiety, and mixed neuropsychiatric presentations, described repeatedly in the literature

This raises an important question that the medical community has not adequately addressed:

How many people currently diagnosed with MS, dementia, treatment-resistant depression, or psychosis actually have an undiagnosed, treatable parasitic infection?

 

Dr. Alan MacDonald’s Findings: The Missing Link

Dr. Alan MacDonald is an American pathologist and Fellow of the College of American Pathologists. His research represents what may be the most significant finding in MS science in decades. It has received almost no attention from mainstream neurology.

What He Did

Dr. MacDonald obtained frozen spinal fluid samples from 10 confirmed MS patients. These samples had been collected at autopsy between 1984 and 2014 and stored in a brain bank, untouched and unexamined, for up to 30 years.

Why had they never been examined?

Because the international panel responsible for MS diagnosis guidelines, the panel behind the McDonald Criteria, had declared that examining MS spinal fluid for infections is “of no value.”

That is not a scientific conclusion. That is a policy decision. It was made by a panel with declared financial relationships to pharmaceutical companies, as listed in the Declaration of Interests section of the 2017 McDonald Criteria publication.

Dr. MacDonald examined those samples anyway.

What He Found 

• Tapeworm larval cysts in multiple developmental stages in every MS subject tested
• Cystic sacs containing immature larvae each, a Coenurus pattern
• Unique cestode hooklets in every patient
• Juvenile tapeworms, whole and developing in 2 of 10 patients
• Tapeworm oncospheres (hatched eggs) in 2 of 10 patients
• Racemose membrane and calcareous corpuscles in multiple patients
• None of these structures were visible to the naked eye. All were missed entirely during the original neuropathological autopsies

 Because current testing is not accurate, a negative tapeworm test does not rule out the presence of these organisms.

Why This Fits the Established NCC Framework

Dr. MacDonald’s findings are not an isolated outlier. They fit directly into what mainstream medicine already accepts about neurocysticercosis:

• Tapeworm cysts in the CNS cause seizures, headaches, focal neurological deficits, gait problems, dementia, depression, psychosis, and MS-like white matter lesions. This is documented
• MacDonald found those same cysts in 100% of the MS spinal fluid samples he examined
• A published peer-reviewed paper titled “Multiple Sclerosis and Neurocysticercosis: A Diagnostic Dilemma” documents that neurologists cannot reliably distinguish between the two conditions by MRI, symptoms, or spinal fluid analysis alone
• The same patient has received both diagnoses at different points in their medical history, in documented cases

Dr. MacDonald’s contribution is not to propose something new and unproven. It is to find evidence of a well-established, well-documented, treatable parasitic disease in the spinal fluid of MS patients, spinal fluid that no one had thought to examine.

 

Testing Options

The good news is that testing for neurocysticercosis does not require new or experimental tools. The tests already exist.

Imaging

• CT scan: superior for detecting calcified cysts (the dead stages). Calcifications show clearly on CT
• MRI: more sensitive for active inflammation, edema, cysts in the CSF spaces surrounding the brain, and degenerating cysts
• Both imaging tools together provide the most complete picture

Antibody Blood Testing

Two antibody tests are available:

• EITB (enzyme-linked immunoelectrotransfer blot): the CDC’s preferred test
• ELISA: enzyme-linked immunoassay

Important caveat: both tests can return a false negative result, particularly when a patient has only a single cyst, a small number of cysts, or calcified cysts. A negative antibody result is not a definitive all-clear. Imaging and antibody testing should be used together.

Stool Testing

A stool test can identify tapeworm eggs and proglottids (tapeworm segments), which confirms the presence of an adult tapeworm in the gut that may be continuously shedding eggs. But stool tests do not routinely test for worms.

Energy Testing

Practitioners using methods such as autonomic response testing, applied kinesiology, electroacupuncture (EAV), Autonomic Response Testing (ART) or acupuncture meridian assessment (AMA) can assess which parasite medications test well for a specific patient. This can be particularly useful when conventional testing returns negative results but the clinical picture points toward a parasitic infection.

 

Before Starting Any Treatment: Mandatory Step

An eye examination must be completed before beginning any anti-parasitic treatment.

If tapeworm cysts are present in or near the eye, they must be surgically removed first. Beginning anti-parasitic drug treatment with cysts present in the eye can cause a severe inflammatory response that may result in permanent vision damage.

If a spinal tap is being ordered, patients have the right to ask their neurologist to examine the spinal fluid under microscopy for possible parasitic organisms. There is now published scientific justification for making that request.

 

Treatment Options

Treatment for neurocysticercosis is established in mainstream medical guidelines. The following information comes from CDC guidelines and peer-reviewed literature.

CDC-Recognized Treatment Protocols

Combination anti-parasitic therapy: albendazole and praziquantel used together

• The combination is significantly more effective than albendazole alone
• Requires the right doses, used for an adequate duration, under medical supervision.

Corticosteroids such as dexamethasone, used alongside anti-parasitic medication

• Reduces the inflammatory die-off reaction as cysts are killed
• Critical for patients with a seizure history. A severe die-off reaction can trigger dangerous seizure activity.

Anti-seizure medication, used during treatment for patients with epilepsy

Surgery, for severe cases including:

• Large cysts blocking the flow of cerebrospinal fluid
• Ventricular shunting may be necessary
• Cysts in CSF spaces can sometimes be removed endoscopically
• Important: cysts must not be ruptured during surgery. If the sac breaks open, larvae can spread and establish new cysts in other areas.

The Live Disease Free Approach

In the Live Disease Free program, pharmaceutical anti-parasitic treatment is one component of a broader, carefully sequenced approach:

• Diet first: significantly reducing carbohydrate intake to starve parasites and reduce their food supply. Most students begin to feel noticeably better at this stage, before any treatment begins
• Body support phase: building the body’s resilience and organ function before treatment is introduced
• Treatment: using pharmaceutical anti-parasitic medications where appropriate, in combination with oxygen therapies and herbal support. The combination is significantly more effective than any single approach alone.

 

Do not self-treat. Using the wrong dose or the wrong duration can cause parasite drug resistance, making the medication ineffective in the future. Treatment without proper support can also trigger a dangerous die-off reaction. Work with a qualified practitioner who understands how to build a proper treatment plan.

 

Why This Is Not Standard Care

If neurocysticercosis is well-documented, and if Dr. MacDonald’s findings point clearly to tapeworm larvae in MS patients, a reasonable question is: why are millions of MS patients still being told their disease is autoimmune?

Part of the answer lies in a systemic assumption in developed-country medicine: that patients are not exposed to parasites unless they have traveled to a developing country. That assumption is outdated and inaccurate. Tapeworm eggs are present on imported produce, in animals, and through routes of self-infection that require no international travel whatsoever.

But there is a structural issue as well.

The McDonald Criteria, the international guidelines that govern how MS is diagnosed and how drugs are approved, were developed by a panel whose Declaration of Interests (the 2017 edition) lists a full page of pharmaceutical company names as financial supporters. These are the same companies that profit from the sale of MS immunosuppressant drugs.

That same panel declared it is “of no value” to examine MS spinal fluid for parasites or infections, while the cause of MS remains officially unknown.

This is a conflict of interest. And when the financial incentive structure of MS medicine depends on drug sales rather than on identifying and treating root causes, the question of why we still have no cure for MS becomes much easier to understand.

Change in this area requires researchers willing to look where they are told not to look, as Dr. MacDonald has done. It requires forward-thinking practitioners willing to investigate infectious causes. And it requires patients who understand their options and demand better care.

 CLICK HERE To review images of tapeworm larvae cysts in the central nervous system of every MS subject tested by Dr. Alan McDonald

There Is Real Hope

Pam Bartha was diagnosed with MS at age 28 after a childhood spent on a farm with significant parasite exposure. She had classic childhood parasite symptoms: chronic gut pain, constipation, difficulty maintaining weight, appendicitis complications, and anemia. None of these were investigated as a possible parasitic infection.

She has been MS free now for over 35 years. Not because her immune system stopped attacking itself. Because she identified and treated the infections driving the disease.

Live Disease Free Academy has now served more than 2,000 students in over 15 countries. The results they report include:

• A student whose hand had been clenched like a claw for 40 years. It opened after the diet and oxygen therapy phases
• A student with years of diplopia (eyes unable to focus or track) whose eyes refocused and began tracking normally after beginning the program
• Students unable to walk without a cane who are walking again

 

These results are not coincidences. They reflect a principle that the research supports: much of what appears to be permanent neurological damage in MS is actually inflammation.

Inflammation is reversible when you remove the cause. The nerve itself may not be permanently damaged. The inflammation surrounding it is what is causing the dysfunction. When that inflammation is reduced by treating the underlying infection, function can return.

That is why students consistently recover more than they or their neurologists expected.

 

What to Do Next

If this information is relevant to you or someone you care about, here are practical next steps:

• Share this post with any practitioner who may be open to investigating parasitic causes
• Ask your doctor about testing for neurocysticercosis, specifically the EITB antibody test, MRI and CT imaging, and stool testing for tapeworm eggs and proglottids
• If you are having a spinal tap, ask whether the spinal fluid can be examined under microscopy for parasitic organisms
• Have an eye examination before starting any anti-parasitic treatment
• Review the Live Disease Free diet guidelines as a starting point. Reducing carbohydrate intake begins to change the internal environment that supports parasitic infections

 

There are real solutions to recover from parasites today!

To restore health, we must focus on treating the cause of inflammation, which are parasites. First, identify the enemy (parasites), then support the body and treat the parasites while following a holistic approach. When parasitic infections are treated effectively, we can overcome inflammation or disease.

If you’re frustrated with the fact that our standard of care STILL doesn’t offer a real solution for treating MS and other diseases, then click on the link below to watch Pam Bartha’s free masterclass training and discover REAL solutions that have allowed Pam and many others to live free from MS and other diseases.

CLICK Here to watch Pam’s masterclass training

 

 

References:

• MacDonald AB. Novel brain compartment tapeworm larvae: possible environmental initiators of demyelination in multiple sclerosis. Eur J Microbiol Immunol. 2021.
  • Key finding: Autopsy cerebrospinal fluid from 10 MS patients contained microscopic cestode larval parasites (coenurus-type cysts, hooklets, oncospheres, juvenile worms) in every subject examined, all missed on original neuropathology.
  • URL: https://www.ilads.org/wp-content/uploads/2021/05/ECMI-17-01109-Novel-brain-Compartment-Tapeworm-Larvae-in-Multiple-Sclerosis-10-patients-PDF.pdf
• MacDonald AB. Multiple sclerosis autopsy cerebrospinal lateral ventricle fluids demonstrate coenurus parasites – 10 patients – 1984–2014. F1000Research Poster. 2020.
  • Key finding: Poster presentation summarizing coenurus-type tapeworm cysts and multiple immature larvae in lateral ventricle fluids of all 10 MS autopsy cases, supporting a consistent association between MS and CNS cestode larvae.
  • URL: https://f1000research.com/posters/9-1062
• Del Brutto OH, Nash TE, Garcia HH. Diagnosis and treatment of neurocysticercosis. Neurol Clin Pract. 2018;8(2): 120-131.
  • Key finding: Reviews NCC as the most common parasitic infection of the human CNS worldwide and a leading cause of acquired epilepsy; outlines clinical spectrum, imaging features, and standard treatment with albendazole plus praziquantel plus corticosteroids, stressing that imaging and serology must be combined.
  • URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC5889044/
• Nash. Nash TE, Garcia HH. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol. 2011;7(10):584‑594.
           Key finding: Reviews neurocysticercosis as a major cause of acquired seizures and epilepsy worldwide, explains how CT/MRI revolutionized                          recognition of NCC burden, and outlines antiparasitic plus anti‑inflammatory treatment principles.
  URL: https://pubmed.ncbi.nlm.nih.gov/21912406/
• Rodríguez‑Leyva I, et al. Neurocysticercosis and epilepsy: imaging and clinical features. Epileptic Disord. 2023.
  • Key finding: Describes Taenia solium cysts in the brain as a major cause of seizures and epilepsy, emphasizes NCC as a “great imitator” mimicking many neurological disorders, and illustrates how lesion stage and location drive a wide range of clinical pictures.
  • URL: https://onlinelibrary.wiley.com/doi/full/10.1002/epd2.20060
• Hernández‑Ramos F, et al. Prevalence of neurocysticercosis and its characteristics in patients with epilepsy. Trop Med Infect Dis. 2026.
  • Key finding: Confirms that in endemic regions, about 29% of people with epilepsy have NCC lesions on neuroimaging and reiterates that NCC is regarded as a “great imitator” capable of mimicking almost any cerebral disorder.
  • URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12962496/
• Carpio A, et al. Multiple sclerosis and neurocysticercosis: a diagnostic dilemma. Rev Neurol. 2004;38(9): 842‑846; updated commentary 2024.
  • Key finding: Presents patients initially diagnosed with NCC who were later diagnosed with MS, stressing that clinical signs, MRI lesions, and CSF tests can overlap so much that careful longitudinal follow‑up is needed to distinguish MS from NCC.
  • URL: https://www.imrpress.com/journal/rn/38/9/10.33588/rn.3809.2003640
• Radiopaedia.org. Neurocysticercosis. Updated 2025.
  • Key finding: Summarizes the four classic stages of NCC (vesicular, colloidal vesicular, granular nodular, nodular calcified) and links each stage to specific MRI/CT features, directly paralleling “enhancing” versus “non‑enhancing” lesions language used in MS.
  • URL: https://radiopaedia.org/articles/neurocysticercosis
• Ranjan P, et al. Neurocysticercosis: unwinding the radiological conundrum. Pol J Radiol. 2024.
  • Key finding: In a cohort of 250 NCC patients, seizures and headaches were the most common presentations; authors detail the four imaging stages and note that NCC lesions can mimic demyelinating and tumoral processes on MRI.
  • URL: https://www.polradiol.com/Neurocysticercosis-unwinding-the-radiological-conundrum,193968,0,2.html
• White White AC Jr, Coyle CM, Rajshekhar V, et al. Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America and the American Society of Tropical Medicine and Hygiene. Clin Infect Dis. 2018;66(8):e49‑e75.
  • Key finding: Evidence‑based guideline recommending albendazole 15 mg/kg/day plus praziquantel 50 mg/kg/day for 10–14 days for patients with more than two viable parenchymal cysticerci, combined with corticosteroids to control inflammatory reactions, and detailing when surgery and ventricular shunting are indicated for extraparenchymal disease.
  • URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC5928844/ 
• CDC. Clinical care of cysticercosis and neurocysticercosis. Centers for Disease Control and Prevention.
  • Key finding: States that neurocysticercosis is the most common parasitic disease of the CNS and a major cause of adult‑onset seizures, recommends CT plus MRI for diagnosis, and endorses albendazole ± praziquantel with corticosteroids as standard therapy.
  • URL: https://www.cdc.gov/cysticercosis/hcp/clinical-care/index.html
• Cleveland Clinic. Neurocysticercosis: symptoms, causes & treatment.
  • Key finding: Describes NCC as a CNS tapeworm infection causing seizures, headaches, focal deficits, gait problems, hydrocephalus, and psychiatric symptoms, and notes that imaging often reveals multiple ring‑enhancing or calcified lesions.
  • URL: https://my.clevelandclinic.org/health/diseases/neurocysticercosis
• Del Brutto OH. Neurocysticercosis. Neurohospitalist. 2014;4(4):205‑212.
  • Key finding: Reviews how ingestion of Taenia solium eggs leads to larval cysts in the CNS that may remain asymptomatic for years, and explains that when cysts degenerate the resulting inflammatory response and edema cause seizures and focal neurological deficits.
  • URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC4212415/
• Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol. 2014;13(12):1202‑1215.
  • Key finding: Reviews the life cycle (infection after ingestion of T. solium eggs), notes that many CNS cysts remain clinically silent, and describes how degenerating cysticerci trigger inflammation, edema, seizures, and focal deficits depending on number, stage, and location of lesions.
  • URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6108081/
• MacDonald AB. Multiple sclerosis is a parasitosis. Lecture, 2018.
  • Key finding: Summarizes pathological evidence that MS represents a neural larva migrans with migrating larval and adult parasitic worms in CNS tissues, aligning with his autopsy CSF findings in MS patients.
  • URL: https://www.youtube.com/watch?v=EHVXJpDBcmU